tirzepatide and duloxetine demonstrates cardiovascular protection in head-to-head trial with dulaglutide Tirzepatide and Antidepressants: Key Interactions

If the pounds were coming off, but things have slowed down or stopped, it might be time to move up to the next dose

There are two subcategories of IBSIBS-D where diarrhea is a predominant symptom or IBS-C, where constipation symptoms are more frequent

You can read more about the full range of expected side effects when starting GLP-1 treatment to get a broader picture of what to expect

Neuropsychiatric Outcomes With Tirzepatide, Semaglutide, and Other GLP-1 Receptor Agonists [PMID: 42420795] Laboratory literature summary: Neuropsychiatric Outcomes With Tirzepatide, Semaglutide, and Other GLP-1 Receptor Agonists

Side effect preparation: Nausea is the most reported side effect, particularly during the first four to eight weeks as doses increase